The route through which a migraine medicine is administered can be an important part of treatment discussions. Zavzpret is distinctive because it is delivered as a nasal spray rather than a tablet. It is a CGRP receptor antagonist intended for the acute treatment of migraine in adults.
Zavzpret is administered through the nose and is intended for acute treatment of migraine with or without aura in adults.
Nasal administration provides an alternative route for people who may have difficulty taking medicines orally during an attack. Migraine can sometimes involve nausea or vomiting, which may make oral medication less convenient.
Points to understand include:
Choosing an acute migraine treatment involves considering more than the delivery method. Healthcare professionals may review the individual's overall health and migraine characteristics before determining whether a particular medicine is appropriate.
Relevant factors may include:
People should follow the prescribed instructions carefully and review the official prescribing information associated with their treatment.
Zavzpret's nasal formulation provides an alternative way to administer an acute migraine treatment. Its role is connected to both its CGRP receptor mechanism and its delivery route. Anyone considering it should discuss individual circumstances and treatment suitability with a qualified healthcare professional.